These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4822861)

  • 1. Isoelectric focusing of components of the complement system and certain related proteins in human serum.
    Nelson RA; Brebner E
    Immunol Commun; 1974; 3(2):109-32. PubMed ID: 4822861
    [No Abstract]   [Full Text] [Related]  

  • 2. The separation of nine components and two inactivators of components of complement in humansserum.
    Vroon DH; Schultz DR; Zarco RM
    Immunochemistry; 1970 Jan; 7(1):43-61. PubMed ID: 5416393
    [No Abstract]   [Full Text] [Related]  

  • 3. The structure and function of the third component of guinea pig complement. I. The effect of chemical reagents on immune hemolysis and immune adherence reactivity.
    Okuda T
    Immunochemistry; 1973 Jun; 10(6):373-9. PubMed ID: 4738908
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of isoelectric points of guinea pig complement components.
    Mukojima T
    Bull Tokyo Med Dent Univ; 1970 Jun; 17(2):75-88. PubMed ID: 5271548
    [No Abstract]   [Full Text] [Related]  

  • 5. C3b inactivator of man. 3. Further purification and production of antibody to C3b INA.
    Ruddy S; Hunsicker LG; Austen KF
    J Immunol; 1972 Mar; 108(3):657-64. PubMed ID: 4622188
    [No Abstract]   [Full Text] [Related]  

  • 6. The fifth component of the guinea pig complement system. 3. Dissociation and transfer of C5b, and the probable site of C5b fixation.
    Shin HS; Pickering RJ; Mayer MM
    J Immunol; 1971 Feb; 106(2):480-93. PubMed ID: 5545154
    [No Abstract]   [Full Text] [Related]  

  • 7. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation of the sixth component of complement from human serum.
    Arroyave CM; Müller-Eberhard HJ
    Immunochemistry; 1971 Nov; 8(11):995-1006. PubMed ID: 4110102
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between erythrocyte membrane proteins and complement components. II. The identification and peptide composition of complement components C3 and C4 desorbed from erythrocyte membranes.
    Bhakdi S; Knüfermann H; Fischer H; Wallach DF
    Biochim Biophys Acta; 1974 Dec; 373(2):295-307. PubMed ID: 4473230
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion of the fourth complement component studied by crossed immunoelectrophoresis.
    Sjöholm AG; Laurell AB
    Clin Exp Immunol; 1973 Aug; 14(4):515-29. PubMed ID: 4127020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of different serological activities associated with immunoglobulins from sera of rabbits immunized with rat erythrocytes.
    Kastelan M; Vitale L; Vitale B
    Eur J Immunol; 1971 Nov; 1(5):363-6. PubMed ID: 5003356
    [No Abstract]   [Full Text] [Related]  

  • 12. The molecular basis of muscle phosphofructokinase deficiency.
    Layzer RB; Rasmussen J
    Arch Neurol; 1974 Dec; 31(6):411-7. PubMed ID: 4280297
    [No Abstract]   [Full Text] [Related]  

  • 13. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
    Opferkuch W; Loos M; Ringelmann R
    Z Med Mikrobiol Immunol; 1971; 156(2):194-207. PubMed ID: 4995249
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).
    Brade V; Cook CT; Shin HS; Mayer MM
    J Immunol; 1972 Dec; 109(6):1174-81. PubMed ID: 4628703
    [No Abstract]   [Full Text] [Related]  

  • 15. Initiation of C3 cleavage in the alternative complement pathway.
    Fearon DT; Austen KF
    J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
    Volanakis JE; Kaplan MH
    J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
    [No Abstract]   [Full Text] [Related]  

  • 17. Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
    Tamura N; Nelson RA
    J Immunol; 1967 Sep; 99(3):582-9. PubMed ID: 6051385
    [No Abstract]   [Full Text] [Related]  

  • 18. Deficiency of C3 inactivator in man.
    Abramson N; Alper CA; Lachmann PJ; Rosen FS; Jandl JH
    J Immunol; 1971 Jul; 107(1):19-27. PubMed ID: 4997111
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on rat complement: a method for titration of rat C1, C2, C3, C4, as well as C5, and the effect of rabbit nephrotoxic serum on the first five components of complement in rat serum.
    Miyakawa Y; Sekine T; Shibata S; Nishioka K
    J Immunol; 1971 Feb; 106(2):545-51. PubMed ID: 5545159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of erythropoietin with chromatography and isoelectric focusing].
    Andreux JP; Frétault J; Piette M; Leclerc M
    Ann Pharm Fr; 1973 Jan; 31(1):29-36. PubMed ID: 4756098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.